4.4(top 3%)
Impact Factor
4.8(top 3%)
extended IF
110(top 3%)
H-Index
1.6K
authors
3.3K
papers
84.6K
citations
6.2K
citing journals
39.7K
citing authors

Most Cited Articles of Pharmacoeconomics

TitleYearCitations
The validity and reproducibility of a work productivity and activity impairment instrument19931.6K
The Epidemiology of Obesity: A Big Picture20151.2K
Conducting discrete choice experiments to inform healthcare decision making: a user's guide2008807
Determining clinically important differences in health status measures: a general approach with illustration to the Health Utilities Index Mark II1999631
The health economics of bladder cancer: a comprehensive review of the published literature2003593
Multi-attribute health status classification systems. Health Utilities Index1995586
An introduction to Markov modelling for economic evaluation1998578
Handling uncertainty in cost-effectiveness models2000544
A comparative review of generic quality-of-life instruments2000511
The NICE cost-effectiveness threshold: what it is and what that means2008496
Health, Health-Related Quality of Life, and Quality of Life: What is the Difference?2016477
The burden of schizophrenia on caregivers: a review2008460
Epidemiology and burden of illness of rheumatoid arthritis2004446
The Economic Costs of Type 2 Diabetes: A Global Systematic Review2015436
Discrete choice experiments in health economics: a review of the literature2014401
Multi-attribute preference functions. Health Utilities Index1995387
The concept of clinically meaningful difference in health-related quality-of-life research. How meaningful is it?2000339
Good practice guidelines for decision-analytic modelling in health technology assessment: a review and consolidation of quality assessment2006327
A guide to handling missing data in cost-effectiveness analysis conducted within randomised controlled trials2014296
Bayesian methods for evidence synthesis in cost-effectiveness analysis2006296
Neuropathic pain: quality-of-life impact, costs and cost effectiveness of therapy2009288
Cost-effectiveness analysis and the consistency of decision making: evidence from pharmaceutical reimbursement in australia (1991 to 1996)2001278
Standardisation of costs: the Dutch Manual for Costing in economic evaluations2002258
Healthcare resource and lost labour costs of migraine headache in the US1992256
The health-related quality of life and economic burden of constipation2005252